-
Renfu Medicine: Mifepristone tablets passed the consistency evaluation of generic drugs
Time of Update: 2021-04-27
, a subsidiary of the company, received the "Drug Supplementary Application Approval Notice" from the State Food and Drug Administration on mifepristone tablets (notice Book number: 2020B05143), the drug passed the generic drug quality and efficacy consistency evaluation.
-
The Liaoning Provincial Food and Drug Administration issued a public solicitation of opinions on the preparation of four Chinese herbal medicines including yew
Time of Update: 2021-04-27
On March 24, the Liaoning Provincial Food and Drug Administration issued an announcement on publicly soliciting opinions on the processing standards of four Chinese herbal medicines including yew.
-
The treatment of BPDCN by ELZONRIS in Manarini has been approved by the European Commission
Time of Update: 2021-03-09
“ For BPDCN patients in Europe, this is the first time they have the potential to benefit from this treatment for this malignant tumor," said Elcin Barker Ergun, CEO of Menarini Group.
-
A list of the costs of four types of drugs will be made from time to time
Time of Update: 2021-02-13
On December 30, the Sichuan Pharmaceutical Tendering and Procurement Service Center posted a notice on the investigation of the production cost of drugs with abnormal price changes (hereinafter referred to as the "Notice"), which made specific deployment to the investigation of the production cost of price-varying drugs to be carried out in the province from now on.
-
Song Ruixuan, Executive Chairman of the Chinese Pharmaceutical Promotion Association, met with counsellors from the Dutch Embassy in Beijing
Time of Update: 2021-01-18
President Song spoke highly of the achievements of the cooperation between the Chinese Pharmaceutical Promotion Association and the Dutch Embassy during Mr. Peter's term in office, and looked forward to the two sides continuing to deepen cooperation and jointly promote the exchange and development of the pharmaceutical industry between China and the Netherlands.
-
Medical and Health Industry Weekly Report (August 31 - September 4
Time of Update: 2020-11-16
Joint release: Sina Pharmaceuticals, Saidi consultants a week overview of policy and regulations, this week issued three policy documents, respectively, "real-world research to support children's dru
-
The two make fake honey for sale in the vegetable market
Time of Update: 2020-08-31
With sugar , citric acid water, and then added to the hive and eaving flavor to make a "natural honey ." Recently, the Shanghai Food and Drug Administration United Xinzhou District Public Security Bureau security brigade, the production and sale of fake honey nests to carry out inspection .
-
It's sunny! Take the first review of 18 varieties of 15 heavyweight new products
Time of Update: 2020-08-14
-meter net data show that since 2020, 15 generic drugs have been approved for listing, of which 5 are the first imitations; 15 varieties were approved for listing, 5 for the first imitation of July 30, the official website of the State Drug Administration shows that Nanjing Zhengda Tianqing Pharmaceuticals to copy 4 categories of production of The Levatsaban film was approved for listing and regarded as the same through the consistency evaluation.
-
U.S. conducts bird flu vaccine trial
Time of Update: 2020-07-08
the U.S Food and Drug Administration released a report on the of the 26th the first U.S H5N1 avian influenza vaccine is less than expected the report survey of 45 2 0 vaccinators showed that
-
U.S. approves PD-L1 monoantigen Tecentriq for first-line treatment of non-small cell lung cancer
Time of Update: 2020-05-29
The U.S Food and Drug Administration has approved Roche's PD-L1 monoresistic Tecentriq (atezolizumab) for first-line treatment in adult patients with high PD-L1 expression without EGFR or ALK gene
-
Clinical approval for ceftetan disodium injection and API
Time of Update: 2020-04-03
Lizhu Pharmaceutical (01513 HK) announced that its wholly-owned subsidiary, Lizhu pharmaceutical, has independently developed a new chemical medicine category 3.1, cefotetan disodium injection and API
-
The first class 1 new drug of mengke medicine was accepted in Huashen newspaper
Time of Update: 2020-01-06
The latest announcement by the drug evaluation center (CDE) of the State Food and Drug Administration of China shows that the class 1 innovative drug, contezolid (also known as mrx-i), which was decla
-
[heavyweight] after the 2018 deadline was cancelled, the official draft of the reference preparation finally came
Time of Update: 2019-03-29
After the cancellation of the 2018 deadline, the official draft of the reference preparation finally came! On March 28, the State Food and Drug Administration issued the announcement on the issuance o
-
18 enterprises in Jiangsu have obtained GMP certificates, and Jiangsu Yangzi River and Jichuan Pharmaceutical Co., Ltd
Time of Update: 2018-12-07
Jiangsu GMP certification notice (No 11, 2018) In accordance with the provisions of the administrative measures for the certification of drug production quality management specifications issued by the
-
General Department of the State Food and Drug Administration: printing and distributing the key points and judgment principles of clinical trials of medical devices
Time of Update: 2018-11-29
The inspection key points and judgment principles of clinical trials of medical devices are formulated in accordance with the requirements of the administrative measures for registration of medical de
